Mast cell activation syndrome in pain syndromes bladder pain syndrome/interstitial cystitis and vulvodynia.

OA: gold CC-BY-NC-ND-4.0
AI-generated summary by gemini-2.5-flash-lite+body, 2026-08-06

This study found increased mast cells, often activated, in bladder pain syndrome/interstitial cystitis and vulvodynia patients, with specific distributions differentiating BPS/IC subtypes and suggesting mast cell stabilizers as a therapeutic target.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-28 · read from full text

This commentary discusses the role of mast cell activation in bladder pain syndrome/interstitial cystitis and vulvodynia, citing a study that found increased mucosal mast cells in patients with these conditions compared to controls. The authors note that while high mast cell density helps identify BPS/IC with Hunner’s lesions, it cannot distinguish between BPS/IC without lesions and overactive bladder without considering clinical pain symptoms. They further highlight that vulvodynia is characterized by significant mast cell hyperplasia and degranulation, often accompanied by other systemic mast cell activation disorders. Relevance to endometriosis: listed among other pain syndromes where mast cells play a role, though the paper's main focus is bladder pain syndrome and vulvodynia.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 6,791 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Acknowledgements

None. Footnote Conflicts of Interest: The author has no conflicts of interest to declare. Comment on: Ratner V. Mast cell activation syndrome. Transl Androl Urol 2015;4:587-8.

References

- Ratner V. Mast cell activation syndrome. Transl Androl Urol 2015;4:587-8. [PubMed] - van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60-7. [Crossref] [PubMed] - Gamper M, Regauer S, Welter J, et al. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol 2015;193:1994-2000. [Crossref] [PubMed] - Fariello JY, Moldwin RM. Similarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient management. Transl Androl Urol 2015;4:643-52. [PubMed] - Regauer S, Eberz B, Beham-Schmid C. Mast cell infiltrates in vulvodynia represent secondary and idiopathic mast cell hyperplasias. APMIS 2015;123:452-6. [Crossref] [PubMed] - Regauer S, Beham-Schmid C. Benign mast cell hyperplasia and atypical mast cell infiltrates in penile lichen planus in adult men. Histol Histopathol 2014;29:1017-25. [PubMed]

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

interstitial_cystitis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-23T09:30:01.253652+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-NC-ND-4.0